Targeting cancer stem cells by nutraceuticals for cancer therapy

Semin Cancer Biol. 2022 Oct:85:234-245. doi: 10.1016/j.semcancer.2021.07.008. Epub 2021 Jul 14.

Abstract

Accumulating evidence has demonstrated that cancer stem cells (CSCs) play an essential role in tumor progression and reoccurrence and drug resistance. Multiple signaling pathways have been revealed to be critically participated in CSC development and maintenance. Emerging evidence indicates that numerous chemopreventive compounds, also known as nutraceuticals, could eliminate CSCs in part via regulating several signaling pathways. Therefore, in this review, we will describe the some natural chemopreventive agents that target CSCs in a variety of human malignancies, including soy isoflavone, curcumin, resveratrol, tea polyphenols, sulforaphane, quercetin, indole-3-carbinol, 3,3'-diindolylmethane, withaferin A, apigenin, etc. Moreover, we discuss that eliminating CSCs by nutraceuticals might be a promising strategy for treating human cancer via overcoming drug resistance and reducing tumor reoccurrence.

Keywords: Cancer; Cancer therapy; Natural agents; Signaling pathways; Stem cell.

Publication types

  • Review

MeSH terms

  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Dietary Supplements
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neoplastic Stem Cells / metabolism
  • Signal Transduction

Substances

  • Curcumin